Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesCurrent management of erectile dysfunction after cancer treatment
Current Opinion in Oncology, 06/15/09
Peltier A et al. - Erectile dysfunction postcancer treatment requires multimodal management with early administration of PDE5-Is, combined therapy to maintain erectile tissue oxygenation if necessary with PDE5-Is, intracavernosal injection and transurethral alprostadil or even vacuum erect device, psychological counseling considering erectile dysfunction as a couple's issue. The best modality to optimize postcancer erectile dysfunction management has not yet been standardized and is still challenging.
Related Articles
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/30/09
Relevance Score: 70%
Effects of 12-Month Tadalafil Therapy for Erectile Dysfunction on Couple Relationships: Results from the DETECT Study
The Journal of Sexual Medicine, 10/28/09
Relevance Score: 69%
Evaluation of Microalbuminuria in Patients with Erectile Dysfunction
The Journal of Sexual Medicine, 10/07/09
Relevance Score: 69%
New Drug Udenafil for Erectile Dysfunction in US Trials
Internet Source, 11/10/09
Relevance Score: 68%
The Association of Serum Prolidase Activity and Erectile Dysfunction
Journal of Andrology, 10/23/09
Relevance Score: 68%
Today in Side Effects...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunoglobulin G Fc Receptor FcgammaRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma
Journal of Clinical Oncology, 12/04/09
Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies
Journal of Clinical Oncology, 12/04/09
Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver
The Oncologist, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor